Evolus, Inc. (EOLS) key performance indicators and operating metrics (16 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Profit Margin | 66.90 percent | FY2026-Q1 |
| Adjusted Gross Profit Margin | 68.00 percent | FY2026-Q1 |
| Operating Expenses (Non-Generally Accepted Accounting Principles) | 49.1M | FY2026-Q1 |
| Global Toxin Revenue | 66.4M | FY2026-Q1 |
| Customer Reorder Rate | 71.00 percent | FY2026-Q1 |
| Total Evolus Rewards Redemptions | 255K | FY2026-Q1 |
| Evolus Rewards Members | 1.5M | FY2026-Q1 |
| Gross Profit Margin (Generally Accepted Accounting Principles) | 65.70 percent | FY2025-Q4 |
| Adjusted Gross Profit Margin (Non-Generally Accepted Accounting Principles) | 66.60 percent | FY2025-Q4 |
| Total Purchasing Accounts Increase | 600.00 | FY2025-Q4 |
| Repeat Treatment Rate | 70.00 percent | FY2025-Q4 |
| United States Account Penetration | 55.00 percent | FY2025-Q4 |
| Evolus Rewards Redemptions | 244K | FY2025-Q3 |
| Total Customers Purchasing Since Launch | 16.5K | FY2025-Q2 |
Back to EOLS overview · EOLS earnings · EOLS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.